Skip to content
Laromustine
Laromustine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
17 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C955418
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myelodysplastic syndromesD009190D46324
LymphomaD008223C85.9313
GlioblastomaD005909EFO_0000515111
Myeloid leukemia acuteD015470C92.0111
Lung neoplasmsD008175C34.9011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Central nervous system neoplasmsD01654322
NeoplasmsD009369C8022
Hematologic neoplasmsD01933711
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Tobacco use disorderD014029F1711
Substance-related disordersD019966EFO_0003890F1311
Smoking cessationD016540EFO_000431911
Tobacco smokingD00007386911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLAROMUSTINE
INNlaromustine
Description
Laromustine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification
Small molecule
Drug classantineoplastics (chloroethylamine derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CNC(=O)N(N(CCCl)S(C)(=O)=O)S(C)(=O)=O
Identifiers
PDB
CAS-ID173424-77-6
RxCUI
ChEMBL IDCHEMBL167691
ChEBI ID
PubChem CID
DrugBank
UNII ID14J2G0U3NQ (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 87 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1 adverse events reported
View more details